NCT06190197
Prophylactic Antibiotics in Cystectomy With Diversion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 8 words Show 4 more changesShow less
- Trial completed
- Final enrollment: 53 participants (planned 120)
- Primary completion date changed from estimate of Oct 15, 2027 to Oct 26, 2026
- Site details revised
- Notable Primary and study completion dates: Oct 15, 2026 to Oct 15, 2027
- Eligibility criteria expanded, about 3 words
- Site contact updated
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Apr 15, 2024 to May 13, 2024
- Site details revised
- Notable Start date: Feb 28, 2024 to Apr 15, 2024
- Primary and study completion dates: Aug 28, 2026 to Oct 15, 2026
- Notable Start date: Jan 2, 2024 to Feb 28, 2024
- Primary and study completion dates: Jul 1, 2026 to Aug 28, 2026
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
test for non-inferiority
Timeframe: 90 days
Difference in risk
Timeframe: 30 and 90 days
Arms and interventions
Control groupNo intervention
No prophylactic antibiotics post operatively. Participants will receive antibiotics only if needed post-operatively such as for infection
Treatment groupExperimental
Prophylactic antibiotics postoperatively.
Drugs: Prophylactic antibiotics postoperatively.
Sites
1 site in 1 country
- University of MinnesotaMinneapolis, Minnesota, United States